BSPM Stock Analysis
BS
Uncovered
Biostar Pharmaceuticals Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
BioStar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of pharmaceutical and health supplement products for a variety of diseases and conditions. The company is headquartered in Xianyang, Shaanxi. The company went IPO on 2008-07-09. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, manufactures and markets pharmaceutical products for various diseases and conditions in the People's Republic of China (PRC or China). The firm offers over-the-counter (OTC) products and prescription-based pharmaceuticals. The firm's products are sold in approximately 30 provinces in the PRC through a network of over 60 distributors and through approximately 230 sales people. The firm's products include XinAoxing Oleanolic Acid Capsule, Ganwang Compound Paracetamol Capsule, Tianqi Dysmenorrhea Capsule, Compound Paracetamol and Amantadine Hydrochloride Tablets, Deafness Tongqiao pills and Huangyangning Tablets.